Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sharing The Risk: Companies Turn To Multi-Sponsored Educational Programs

Executive Summary

Pharma companies are turning to multi-sponsored continuing medical education programs as a way to mitigate risks in a climate where company-sponsored educational programs draw increased scrutiny
Advertisement

Related Content

CME Accrediting Policies Being Revised As Congress Eyes Compliance Issues
CME Accrediting Policies Being Revised As Congress Eyes Compliance Issues
Medical Education Shows Impact On Prescribing Behavior, Survey Says
Medical Education Shows Impact On Prescribing Behavior, Survey Says
Medical Education Shows Impact On Prescribing Behavior, Survey Says
Industry-Sponsored CME Still On FDA Radar, McNeil Exec Says
Pfizer To Monitor Off-Label Drug Use Under Neurontin Settlement
Pfizer To Monitor Off-Label Drug Use Under Neurontin Settlement
IG Compliance Guide Approach To CME, Consulting Concerns PhRMA
FDA FINAL CME POLICY ALLOWS GENERAL STATEMENT ON OFF-LABEL USES INSTEAD OF DISCLOSURE FOR EACH USE DISCUSSED; WRITTEN AGREEMENTS LESS EMPHASIZED
Advertisement
UsernamePublicRestriction

Register

PS047502

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel